αααααβααΎαRMD β’ ASX
add
Resmed CDI
37.41$
23 ααααΆ, 8:30:03 PM ααααβααα +11 · AUD · ASX · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
AUααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
38.44$
α
αααααααααααα
36.60$ - 37.48$
α
ααααααα½αααααΆαα
α»αααααα
32.04$ - 45.25$
ααΎαβαα»αβααΈααααΆα
37.04Β αααΈααΆα USD
ααα ααα½αααΌαααααα
759.10Β ααΆαα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 1.34Β αααΈααΆα | 9.07% |
α
αααΆαααααα·ααααα·ααΆα | 366.29Β ααΆα | 8.51% |
α
αααΌααα»ααα | 348.54Β ααΆα | 11.94% |
ααααΆααα
αααααα»ααα | 26.10 | 2.63% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 2.55 | 1,059.09% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 503.64Β ααΆα | 18.34% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 21.99% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 1.38Β αααΈααΆα | 224.57% |
ααααααααα»α | 8.31Β αααΈααΆα | 15.04% |
ααΆαααα½ααα»αααααΌαααα»α | 2.19Β αααΈααΆα | 7.88% |
ααΌαβααααα»α | 6.12Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 145.97Β ααΆα | β |
ααααααααααΉαααααα
| 0.92 | β |
ααα
ααααααΎαααααα | 14.02% | β |
ααα
ααααααΎααΎααα»α | 16.77% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 348.54Β ααΆα | 11.94% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 457.32Β ααΆα | 40.48% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -52.58Β ααΆα | -2,550.05% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -230.27Β ααΆα | -52.75% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 174.40Β ααΆα | -7.24% |
ααα αΌαααΆα
αααααΆααααααα | 363.20Β ααΆα | 92.59% |
α’αααΈ
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
ααΆααααααΎαα‘αΎα
αα·αα»ααΆ 1989
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
10,600